Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
Key Metrics
as of Sep 2026
Market Cap 3,919 Cr
P/E 74.80
Div Yield 0.12 %
Book Value โน334.00
52w High โน1,839.00
52w Low โน976.00
Face Value โน10.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
147.00
133.00
139.00
116.00
109.00
108.00
84.00
81.00
94.00
94.00
86.00
93.00
106.00
Expenses
123.00
106.00
112.00
95.00
94.00
100.00
78.00
76.00
86.00
80.00
74.00
72.00
86.00
Operating Profit
24.00
27.00
27.00
21.00
15.00
8.00
6.00
5.00
8.00
14.00
12.00
21.00
20.00
OPM %
16.00
20.00
19.00
18.00
14.00
7.00
7.00
6.00
8.00
15.00
14.00
22.00
18.00
Other Income
3.00
0.00
2.00
1.00
1.00
1.00
0.00
1.00
1.00
5.00
1.00
1.00
1.00
Depreciation
11.00
10.00
9.00
9.00
9.00
7.00
7.00
7.00
7.00
6.00
7.00
7.00
6.00
Interest
2.00
1.00
0.00
1.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.00
3.00
Profit before tax
14.00
15.00
19.00
12.00
7.00
2.00
-2.00
-2.00
2.00
12.00
7.00
12.00
12.00
Tax %
26.00
40.00
15.00
28.00
27.00
30.00
-30.00
-30.00
29.00
33.00
29.00
30.00
30.00
Net Profit
10.00
9.00
16.00
9.00
5.00
1.00
-1.00
-1.00
2.00
8.00
5.00
8.00
8.00
EPS in Rs
4.47
3.86
6.83
3.82
2.19
0.47
-0.50
-0.47
0.65
3.53
1.99
3.51
3.72
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Sales
496.00 366.00 379.00 403.00 428.00 291.00 254.00 203.00 131.00
Expenses
407.00 340.00 312.00 348.00 322.00 226.00 201.00 170.00 110.00
Operating Profit
90.00 26.00 67.00 55.00 106.00 65.00 53.00 33.00 22.00
OPM %
18.00 7.00 18.00 14.00 25.00 22.00 21.00 16.00 16.00
Other Income
3.00 3.00 7.00 2.00 11.00 5.00 1.00 1.00 2.00
Interest
3.00 1.00 7.00 9.00 5.00 4.00 4.00 4.00 3.00
Depreciation
37.00 28.00 26.00 10.00 8.00 7.00 5.00 4.00 3.00
Profit before tax
53.00 0.00 42.00 39.00 103.00 59.00 44.00 26.00 18.00
Tax %
26.00 28.00 31.00 -4.00 7.00 13.00 21.00 24.00 38.00
Net Profit
39.00 0.00 29.00 40.00 96.00 51.00 35.00 20.00 11.00
EPS in Rs
16.71 0.14 12.55 18.26 43.31 25.57 43.51 25.13 13.74
Dividend Payout %
12.00 709.00 16.00 11.00 5.00 20.00 0.00 0.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Equity Capital
23.00 23.00 23.00 22.00 22.00 20.00 8.00 8.00 8.00
Reserves
735.00 698.00 702.00 483.00 447.00 142.00 106.00 72.00 51.00
Borrowings
120.00 36.00 14.00 170.00 120.00 90.00 91.00 77.00 56.00
Other Liabilities
117.00 65.00 75.00 80.00 87.00 58.00 40.00 31.00 29.00
Total Liabilities
995.00 823.00 815.00 755.00 676.00 310.00 245.00 187.00 145.00
Fixed Assets
609.00 529.00 427.00 196.00 160.00 120.00 111.00 67.00 57.00
CWIP
25.00 24.00 77.00 231.00 51.00 10.00 5.00 6.00 10.00
Investments
5.00 1.00 11.00 1.00 1.00 1.00 1.00 1.00 1.00
Other Assets
356.00 269.00 301.00 327.00 464.00 179.00 129.00 114.00 76.00
Total Assets
995.00 823.00 815.00 755.00 676.00 310.00 245.00 187.00 145.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activity
29.00 24.00 103.00 24.00 20.00 19.00 25.00
Cash from Investing Activity
-116.00 -65.00 -121.00 -101.00 -197.00 -21.00 -40.00
Cash from Financing Activity
79.00 17.00 31.00 38.00 235.00 -5.00 10.00
Net Cash Flow
-8.00 -25.00 13.00 -40.00 58.00 -6.00 -6.00
Free Cash Flow
-84.00 -52.00 -26.00 -179.00 -69.00 -2.00 -24.00
CFO/OP %
37.00 109.00 163.00 57.00 36.00 44.00 61.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Debtor Days
106.00 90.00 66.00 82.00 53.00 113.00 73.00 80.00 92.00
Inventory Days
268.00 228.00 313.00 249.00 299.00 168.00 165.00 98.00 134.00
Days Payable
91.00 60.00 96.00 52.00 82.00 116.00 88.00 70.00 132.00
Cash Conversion Cycle
283.00 258.00 282.00 278.00 269.00 166.00 150.00 109.00 94.00
Working Capital Days
80.00 139.00 154.00 22.00 72.00 73.00 45.00 46.00 16.00
ROCE %
7.00 0.00 7.00 8.00 26.00 28.00 27.00 22.00 โ
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
72.02
72.02
72.02
72.02
72.02
72.02
72.02
72.02
72.02
72.02
72.02
72.02
FIIs
3.93
3.81
4.17
3.40
3.26
3.30
3.36
3.33
3.37
3.65
4.21
4.40
DIIs
3.11
2.99
3.32
3.87
5.11
5.46
6.34
6.83
10.64
12.84
13.06
13.78
Public
20.94
21.16
20.49
20.72
19.60
19.21
18.27
17.81
13.97
11.49
10.72
9.79
No. of Shareholders
64,921
66,842
68,657
73,331
76,792
78,393
79,009
79,623
73,912
73,730
74,519
74,628
Corporate Actions
8 records
Back to all stocks